Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events
Contact
Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events

Interviews

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Expert Opinion: Suzanne Snellenberg, PhD

July 18, 2023

Expert Opinion: Suzanne Snellenberg, PhD

Editor's note: In this installment of Expert Opinion, Suzanne Snellenberg, PhD, Director of ...

Sustaining momentum in iPSC-derived allogeneic cell therapies

March 30, 2023

Sustaining momentum in iPSC-derived allogeneic cell therapies

As published in Drug Target Review - March/April 2023 Issue Drug Target Review connects with ...

iPSCs in the cell therapy landscape: Interview with Elena Matsa

January 30, 2023

iPSCs in the cell therapy landscape: Interview with Elena Matsa

How has the cell therapy landscape evolved in the past ten years, particularly in regard to ...

The value of capability in allogeneic cell therapy: an interview with Andy Holt

January 16, 2023

The value of capability in allogeneic cell therapy: an interview with Andy ...

In this interview, we spoke to Andy about Cellistic’s recent acquisition of a GMP facility and ...

Expert Opinion: Benjamin Demoulin, PhD

January 10, 2023

Expert Opinion: Benjamin Demoulin, PhD

Editor's note: In this installment of Expert Opinion, Benjamin Demoulin, PhD, Director of Cell ...

Expert Opinion: Elena Matsa, PhD

November 17, 2022

Expert Opinion: Elena Matsa, PhD

Editor’s Note: In this installment of Expert Opinion, Elena Matsa, PhD, VP of Cell Technology ...

Cellistic Logo White
  • Services
  • Technologies
  • Cell Types
  • Facility
  • Resources
  • About
  • Contact
  • Team
  • Careers
x-twitter InBug-White-1

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium

 

partnering@cellistic.com

  • Privacy Policy
  • Cookie Policy